Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Akebia Therapeutics, Inc. (AKBA) had Receiveable Turnover of 1.22 for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
$32.61M |
|
$-17.98M |
|
$11.61M |
|
$21.00M |
|
$47.54M |
|
$-14.94M |
|
$-3.05M |
|
$-17.98M |
|
$-17.98M |
|
$-17.98M |
|
$-17.98M |
|
$-17.98M |
|
$-17.98M |
|
$-14.94M |
|
$-5.56M |
|
204.96M |
|
204.96M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$112.94M |
|
$3.27M |
|
$112.53M |
|
$225.48M |
|
$66.49M |
|
$30.14M |
|
$186.25M |
|
$252.74M |
|
$-27.26M |
|
$-113.33M |
|
$-27.26M |
|
209.45M |
|
| Cash Flow Statement Financials | |
$-19.43M |
|
-- |
|
$18.48M |
|
$44.58M |
|
$43.62M |
|
$-0.96M |
|
$2.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.70 |
|
-- |
|
-- |
|
10.44 |
|
-1.11 |
|
64.41% |
|
-45.81% |
|
-45.81% |
|
-- |
|
-55.16% |
|
-55.16% |
|
$-19.43M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.45 |
|
|
Receiveable Turnover |
1.22 |
73.47 |
|
65.98% |
|
15.87% |
|
-7.98% |
|
-622.96% |
|
$-0.13 |
|
$-0.09 |
|
$-0.09 |
|